BioCentury
ARTICLE | Company News

IDAC, Ono Pharmaceutical deal

May 23, 2016 7:00 AM UTC

IDAC granted Ono the exclusive right to evaluate and negotiate a license for IT1208. Ono has rights to evaluate data from a Japanese Phase I trial to treat solid tumors to be conducted by IDAC. IT120...